Egorov, Puginsky, Afanasiev & Partners has successfully represented the interests of the Orion Corporation, a Finnish pharmaceutical company, before the Cassation Appeal instance court in a patent dispute.
Orion Corporation went to court to demand that a Russian manufacturer marketing generic drugs which infringed on Orion's patent for the “Pharmaceutical solutions of Levosimendan” — which Orion uses to prepare heart failure drug Simdaks — discontinue its production.
Both the court of first instance and the Appellate Court found against the Orion Corporation and refused to grant its demand. At the stage of cassation appeal, however, the decisions of the lower courts were voided and the intellectual property department sent the case for a retrial at the first instance.
The EPAM team included Partners Valery Eremenko and Dmitry Dyakin, Counsels Vera Richterman and Pavel Sadovsky, Lawyer Maxim Burda, and Junior Lawyer Vladimir Rodionov.